In the US, Tacrine (tacrine systemic) is a member of the drug class cholinesterase inhibitors and is used to treat Alzheimer's Disease.
US matches:
- Tacrine
- Tacrine Hydrochloride
- Tacrine Hydrochloride (Tetrahydroaminoacridine; THA)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06DA01
CAS registry number (Chemical Abstracts Service)
0000321-64-2
Chemical Formula
C13-H14-N2
Molecular Weight
198
Therapeutic Categories
Antidote: Curare antagonist
Anti-dementia agent
Enzyme inhibitor, acetylcholinesterase
Chemical Name
9-Acridinamine, 1,2,3,4-tetrahydro-
Foreign Names
- Tacrinum (Latin)
- Tacrin (German)
- Tacrine (French)
- Tacrina (Spanish)
Generic Names
- Tacrine (OS: BAN, DCF)
- THA (IS)
- Tacrine Hydrochloride (OS: USAN, BANM)
- CI 970 (IS: Parke-Davis)
- Tacrine Hydrochloride (PH: USP 32)
Brand Names
- Talem
LKM, Argentina - Cognex
Genesis, Greece; Pfizer, Chile; Sciele, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment